Position in IBRX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$6,377,064
+$4,630,059 QoQ
Shares Held
831,430
-5.8% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 84.95676124267828.ToString("F0")%
Shared 0.ToString("F0")%
None 15.043238757321722.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,202,987,460 across 269 Biotechnology names. IBRX ranks #76 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in IBRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,377,064 | 831,430 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,747,005 | 882,327 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,866,599 | 758,781 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,939,660 | 734,720 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,511,828 | 502,269 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,278,790 | 499,528 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,879,791 | 505,321 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,928,105 | 621,536 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $2,420,762 | 450,794 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $2,421,821 | 482,435 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $875,802 | 518,227 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,450,625 | 521,808 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $801,404 | 440,333 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,281,240 | 449,949 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,194,244 | 441,498 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,333,090 | 358,358 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,922,983 | 342,778 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,153,656 | 354,220 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,424,389 | 351,580 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $4,427,499 | 310,049 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,960,947 | 166,847 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||